Cargando…

Structure‐Based Design, Synthesis, and Biological Evaluation of Triazole‐Based smHDAC8 Inhibitors

Schistosomiasis is a neglected tropical disease caused by parasitic flatworms of the genus Schistosoma, which affects over 200 million people worldwide and leads to at least 300,000 deaths every year. In this study, initial screening revealed the triazole‐based hydroxamate 2 b (N‐hydroxy‐1‐phenyl‐1H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalinin, Dmitrii V., Jana, Sunit K., Pfafenrot, Maxim, Chakrabarti, Alokta, Melesina, Jelena, Shaik, Tajith B., Lancelot, Julien, Pierce, Raymond J., Sippl, Wolfgang, Romier, Christophe, Jung, Manfred, Holl, Ralph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187165/ https://www.ncbi.nlm.nih.gov/pubmed/31816172 http://dx.doi.org/10.1002/cmdc.201900583

Ejemplares similares

A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing
por: Simoben, Conrad V., et al.
Publicado: (2018)

Binding Free Energy (BFE) Calculations and Quantitative Structure–Activity Relationship (QSAR) Analysis of Schistosoma mansoni Histone Deacetylase 8 (smHDAC8) Inhibitors
por: Simoben, Conrad V., et al.
Publicado: (2021)

Computational Insights into Natural Antischistosomal Metabolites as SmHDAC8 Inhibitors: Molecular Docking, ADMET Profiling, and Molecular Dynamics Simulation
por: Alzain, Abdulrahim A., et al.
Publicado: (2023)

Carbamates as Potential Prodrugs and a New Warhead for HDAC Inhibition
por: King, Kristina, et al.
Publicado: (2018)

Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds
por: Bülbül, Emre F., et al.
Publicado: (2023)

Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoni
por: Marek, Martin, et al.
Publicado: (2013)

Histone deacetylase 8 interacts with the GTPase SmRho1 in Schistosoma mansoni
por: Pagliazzo, Lucile, et al.
Publicado: (2021)

Docking, Binding Free Energy Calculations and In Vitro Characterization of Pyrazine Linked 2-Aminobenzamides as Novel Class I Histone Deacetylase (HDAC) Inhibitors
por: Bülbül, Emre F., et al.
Publicado: (2022)

Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
por: Ghazy, Ehab, et al.
Publicado: (2022)

Continuous Activity Assay for HDAC11 Enabling Reevaluation of HDAC Inhibitors
por: Kutil, Zsófia, et al.
Publicado: (2019)

Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity
por: Darwish, Salma, et al.
Publicado: (2022)

2-Benzazolyl-4-Piperazin-1-Ylsulfonylbenzenecarbohydroxamic Acids as Novel Selective Histone Deacetylase-6 Inhibitors with Antiproliferative Activity
por: Wang, Lei, et al.
Publicado: (2015)

First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement
por: Herp, Daniel, et al.
Publicado: (2022)

Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth
por: Chua, Ming Jang, et al.
Publicado: (2016)

Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity
por: Ibrahim, Hany S., et al.
Publicado: (2021)

Establishing essential quality criteria for the validation of circular RNAs as biomarkers
por: Pfafenrot, Christina, et al.
Publicado: (2019)

Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation
por: Sinatra, Laura, et al.
Publicado: (2023)

The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
por: Vaca, Hugo Rolando, et al.
Publicado: (2021)

Synthesis of new triazole-based trifluoromethyl scaffolds
por: Martinelli, Michela, et al.
Publicado: (2008)

Pharmacophore Elucidation and Molecular Docking Studies on 5-Phenyl-1-(3-pyridyl)-1H-1,2,4-triazole-3-carboxylic Acid Derivatives as COX-2 Inhibitors
por: Lindner, Marc, et al.
Publicado: (2010)

Influence of shell structure on neutron and proton exchange in the reactions $^{144}$Sm on $^{144}$Sm and $^{154}$Sm on $^{154}$Sm
por: Wu, E C, et al.
Publicado: (1981)

Structure–function analysis and genetic interactions of the SmG, SmE, and SmF subunits of the yeast Sm protein ring
por: Schwer, Beate, et al.
Publicado: (2016)

A meta-analysis of hypoxia inducible factor 1-alpha (HIF1A) gene polymorphisms: association with cancers
por: Anam, Md. T, et al.
Publicado: (2015)

Synthesis and Antiproliferative Activity of Triazoles Based on 2-Azabicycloalkanes
por: Steppeler, Franz, et al.
Publicado: (2021)

Draft Genome Sequences of Stenotrophomonas maltophilia Strains Sm32COP, Sm41DVV, Sm46PAILV, SmF3, SmF22, SmSOFb1, and SmCVFa1, Isolated from Different Manures in France
por: Bodilis, Josselin, et al.
Publicado: (2016)

In cellulo and in vivo assays for compound testing against Trypanosoma cruzi
por: Guerra-Slompo, Eloise Pavão, et al.
Publicado: (2023)

Novel C15 Triene Triazole, D-A Derivatives Anti-HepG2, and as HDAC2 Inhibitors: A Synergy Study
por: Qi, Zhiwen, et al.
Publicado: (2018)

Non-SM Exotic Higgs: Beyond SM and MSSM
por: Lacaprara, Stefano
Publicado: (2013)

Recent advances in SmFe(12)-based permanent magnets
por: Takahashi, Y. K., et al.
Publicado: (2021)

Multi-party co-signature scheme based on SM2
por: Tan, Liang, et al.
Publicado: (2023)

Charged Triazole Cross-Linkers for Hyaluronan-Based Hybrid Hydrogels
por: Martini, Maike, et al.
Publicado: (2016)

Theoretical and experimental studies of an oseltamivir–triazole-based thermoresponsive organogel
por: Kumar, Sumit, et al.
Publicado: (2019)

SM benchmarks
por: Rademacker, J
Publicado: (2011)

Beyond the SM
por: Wagner, C
Publicado: (1998)

SM challenges
por: Virto, Javier
Publicado: (2021)

Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast
por: Seo, Jinwon, et al.
Publicado: (2014)

Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma
por: Huang, Renhong, et al.
Publicado: (2018)

Combination of SM, SM4, FP Higgs boson searches
por: CMS Collaboration
Publicado: (2012)

Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6
por: Traoré, Mohamed D. M., et al.
Publicado: (2017)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
por: Thomas, Elizabeth A.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_prmmv5apk790kkjlnde883jj0h